Potential Impact of Schedule III: Everything Cannabis Operators and Consumers Should Know
In October 2022, President Biden requested a U.S. Secretary of Health and Human Services (HHS) administrative review of cannabis’s classification under federal law. After conducting a scientific and medical review of cannabis, HHS issued a recommendation to the U.S. Drug Enforcement Agency (DEA) that cannabis should be recategorized from Schedule I to Schedule III, recognizing […]